Care Management in Hospitalized Patients with Parkinson Disease: Review and Recommendations
DOI:
https://doi.org/10.24950/rspmi.2677Keywords:
Hospitalization, Parkinson Disease/complications, Parkinson Disease/therapy, Patient Care TeamAbstract
Parkinson's Disease (PD) is one of the most common neurodegenerative diseases, characterized by motor symptoms such as tremor, rigidity, and gait disturbances, as well as a variety of non-motor symptoms that significantly impact the functionality of individuals living with this diagnosis. PD is more prevalent in older adults, and as the disease progresses, complications such as falls, neuropsychiatric changes, and autonomic dysfunctions arise, often leading to prolonged and complex hospitalizations.
Hospitalizations in PD can be categorized into three groups: complications directly related to the disease, such as motor fluctuations and neuropsychiatric symptoms; indirect complications, such as aspiration pneumonia and trauma; and causes unrelated to PD. Managing these cases in a hospital setting is challenging and requires a multidisciplinary approach.
This study is a literature review on the management of individuals with PD during hospitalization, aiming to develop evidence-based clinical recommendations to optimize inpatient care. A systematic review of articles on hospital care in PD was conducted, addressing akinetic crisis, autonomic dysfunction, delirium, falls, infections, and therapeutic management. Based on the findings, clinical guidelines tailored to the Portuguese healthcare context were developed to improve the safety and efficacy of care provided to this vulnerable population.
Downloads
References
Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013. doi: 10.1038/nrdp.2017.13
Ferreira JJ, Goncalves N, Valadas A, Januario C, Silva MR, Nogueira L, et al. Prevalence of Parkinson's disease: a population-based study in Portugal. Eur J Neurol. 2017;24;748-50. doi: 10.1111/ene.13273.
Oguh O, Videnovic A. Inpatient management of Parkinson disease: current challenges and future directions. Neurohospitalist. 2012;2:28–35. doi: 10.1177/1941874411427734
Gerlach OH, Broen MP, Weber WE. Motor outcomes during hospitalization in Parkinson's disease patients: a prospective study. Parkinsonism Relat Disord. 2013;19:737–41. doi: 10.1016/j.parkreldis.2013.04.017
Su CM, Kung CT, Chen FC, Cheng HH, Hsiao SY, Lai YR, et al. Manifestations and outcomes of patients with Parkinson's disease and serious infection in the emergency department. Biomed Res Int. 2018;2018:6014896. doi: 10.1155/2018/6014896
Hogg E, Frank S, Oft J, Benway B, Rashid MH, Lahiri S. Urinary tract infection in Parkinson's disease. J Parkinsons Dis. 2022;12:743–57. doi: 10.3233/JPD-213103
McMillan JM, Michalchuk Q, Goodarzi Z. Frailty in Parkinson's disease: A systematic review and meta-analysis. Clin Parkinsonism Relat Disord. 2021;4:100095. doi: 10.1016/j.prdoa.2021.100095
Phillips OW, Kunicki Z, Jones R, Belanger E, Shireman TI, Friedman JH, et al. Inpatient mortality in Parkinson's disease. Neurohospitalist. 2023;13:144–52. doi: 10.1177/19418744231153477
Martins J, Rua A, Vila Cha N. Mortalidade hospitalar na doenca de Parkinson: analise retrospetiva num hospital terciario portugues. Acta Med Port. 2016;29:315–8.
Corrado J, Jackson O, Baxandall D, Robson J, Duggan-Carter P, Throssell J, et al. Get Parkinson's medications on time: the Leeds QI project. Age Ageing. 2020;49:865–72. doi: 10.1093/ageing/afaa142
Yu JRT, Sonneborn C, Hogue O, Ghosh D, Brooks A, Liao J, et al. Establishing a framework for quality of inpatient care for Parkinson's disease: A study on inpatient medication administration. Parkinsonism Relat Disord. 2023;113:105491. doi: 10.1016/j.parkreldis.2023.105491
Yu JRT, Sokola BS, Walter BL. Optimization of inpatient medication administration among persons with Parkinson's disease: recommendations on pharmacy technology and workflow. Front Pharmacol. 2023;14:1254757. doi: 10.3389/fphar.2023.1254757
Lertxundi Etxebarria U, Palacios-Zabalza I, Ibarrondo I, Domingo-Echaburu S, Hernandez R, Isla A, et al. Pharmacotherapeutic management of Parkinson's disease inpatients: how about asking hospital pharmacists?. Eur J Hosp Pharm Sci Pract. 2021;28:e140–7. doi: 10.1136/ejhpharm-2020-002461
Segal O, Hassin-Baer S, Rosman M, Segal G. Decreased dopaminergic treatment of hospitalized Parkinson's disease patients during infectious diseases is associated with poor outcomes. J Clin Neurosci. 2015;22:1272–4. doi: 10.1016/j.jocn.2015.02.010
Segal O, Hassin-Baer S, Kliers I, Gringouz I, Dagan A, Cohen S, et al. Decreased Anti-Parkinson's Therapy during Hospitalization due to Infectious Diseases is Associated with Worse Prognosis. CNS Neurosci Ther. 2016;22:423–5. doi: 10.1111/cns.12545
MacMahon MJ, MacMahon DG. Management of Parkinson's disease in the acute hospital environment. J R Coll Physicians Edinb. 2012;42:157–62. doi: 10.4997/JRCPE.2012.215
Lertxundi U, Isla A, Solinis MA, Domingo-Echaburu S, Hernandez R, Peral-Aguirregoitia J, et al. Anticholinergic burden in Parkinson's disease inpatients. Eur J Clin Pharmacol. 2015;71:1271–7. doi: 10.1007/s00228-015-1919-7
Thomas A, Iacono D, Luciano AL, Armellino K, Onofrj M. Acute akinesia or akinetic crisis in Parkinson's disease. Neurol Sci. 2003;24:219–20. doi: 10.1007/s10072-003-0139-6
Onofrj M, Thomas A. Acute akinesia in Parkinson disease. Neurology. 2005;64:1162–9. doi: 10.1212/01.WNL.0000157058.17871.7B
Catic AG. Identification and management of in-hospital drug-induced delirium in older patients. Drugs Aging. 2011;28:737–48. doi: 10.2165/11592240-000000000-00000.
Lawson RA, Richardson SJ, Yarnall AJ, Burn DJ, Allan LM. Identifying delirium in Parkinson disease: A pilot study. Int J Geriatr Psychiatry. 2020;35:547–52. doi: 10.1002/gps.5270.
McLaughlin NC, Piryatinsky I, Epstein-Lubow G, Marino L, Friedman JH. Neuropsychiatric symptoms in an inpatient Parkinson's disease sample. Parkinsons Dis. 2014;2014:420240. doi: 10.1155/2014/420240.
Hermanowicz N, Edwards K. Parkinson's disease psychosis: symptoms, management, and economic burden. Am J Manag Care. 2015;21:s199–s206.
Aminoff MJ, Christine CW, Friedman JH, Chou KL, Lyons KE, Pahwa R, et al. Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. Parkinsonism Relat Disord. 2011;17:139–45. doi: 10.1016/j.parkreldis.2010.11.009.
Cullinan RJ, Richardson SJ, Yarnall AJ, Burn DJ, Allan LM, Lawson RA. Documentation and diagnosis of delirium in Parkinson's disease. Acta Psychiatr Scand. 2023;147:527–35. doi: 10.1111/acps.13470.
Ceppi MG, Rauch MS, Spondlin J, Gantenbein AR, Meier CR, Sandor PS. Potential risk factors for, and clinical implications of, delirium during inpatient rehabilitation: A matched case-control study. J Am Med Dir Assoc. 2023;24:519–25.e6. doi: 10.1016/j.jamda.2023.01.012.
Gerakios F, Yarnall AJ, Bate G, Wright L, Davis D, Stephan BC, et al. Delirium is more common and associated with worse outcomes in Parkinson's disease compared to older adult controls: results of two prospective longitudinal cohort studies. Age Ageing. 2024;53:afae046. doi: 10.1093/ageing/afae046.
Carrarini C, Russo M, Dono F, Barbone F, Rispoli MG, Ferri L, et al. Agitation and dementia: prevention and treatment strategies in acute and chronic conditions. Front Neurol. 2021;12:644317. doi: 10.3389/fneur.2021.644317.
Nemet M, Andrijevic A, Nedeljkov Đ, Andric V, Gavrilovic S. A case report on serotonin syndrome in a patient with Parkinson's disease: diagnostic and management challenges. Cureus. 2023;15:e36780. doi: 10.7759/cureus.36780.
Katus L, Shtilbans A. Perioperative management of patients with Parkinson's disease. Am J Med. 2014;127:275–80. doi: 10.1016/j.amjmed.2013.11.014.
Warnecke T, Schafer KH, Claus I, Del Tredici K, Jost WH. Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management. NPJ Parkinsons Dis. 2022;8:31. doi: 10.1038/s41531-022-00295-x.
Vallelonga F, Valente M, Tangari MM, Covolo A, Milazzo V, Di Stefano C, et al. Hypotensive episodes at 24-h ambulatory blood pressure monitoring predict adverse outcomes in Parkinson's disease. Clin Auton Res. 2024;34:281–91. doi: 10.1007/s10286-024-01030-7.
Merola A, Sawyer RP, Artusi CA, Suri R, Berndt Z, Lopez-Castellanos JR, et al. Orthostatic hypotension in Parkinson disease: impact on health care utilization. Parkinsonism Relat Disord. 2018;47:45–9. doi: 10.1016/j.parkreldis.2017.11.344.
Feldstein C, Weder AB. Orthostatic hypotension: a common, serious and underrecognized problem in hospitalized patients. J Am Soc Hypertens. 2012;6:27–39. doi: 10.1016/j.jash.2011.08.008.
Merola A, Romagnolo A, Rosso M, Lopez-Castellanos JR, Wissel BD, Larkin S, et al. Orthostatic hypotension in Parkinson's disease: does it matter if asymptomatic? Parkinsonism Relat Disord. 2016;33:65–71. doi: 10.1016/j.parkreldis.2016.09.013.
Schrag A, Choudhury M, Kaski D, Gallagher DA. Why do patients with Parkinson's disease fall? A cross-sectional analysis of possible causes of falls. NPJ Parkinsons Dis. 2015;1:15011. doi: 10.1038/npjparkd.2015.11.
Radder DLM, Nonnekes J, Bloem BR. Intensive inpatient rehabilitation for persons with Parkinson's disease: last resort or pre-emptive strike? J Neurol Neurosurg Psychiatry. 2018;89:795–6. doi: 10.1136/jnnp-2017-317812.
Radder DL, Nonnekes J, van Nimwegen M, Eggers C, Abbruzzese G, Alves G, et al. Recommendations for the organization of multidisciplinary clinical care teams in Parkinson's disease. J Parkinsons Dis. 2020;10:1087–98. doi: 10.3233/JPD-202078.
Marumoto K, Yokoyama K, Inoue T, Yamamoto H, Kawami Y, Nakatani A, et al. Inpatient enhanced multidisciplinary care effects on the quality of life for Parkinson disease: a quasi-randomized controlled trial. J Geriatr Psychiatry Neurol. 2019;32:186–94. doi: 10.1177/0891988719841721.
Meloni M, Saibene FL, Di Tella S, Di Cesare M, Borgnis F, Nemni R, et al. Functional and cognitive improvement after an intensive inpatient multidisciplinary rehabilitation program in mild to severe Parkinson's disease: a retrospective and observational study. Front Neurol. 2021;12:626041. doi: 10.3389/fneur.2021.626041.
Kaseda Y, Ikeda J, Sugihara K, Yamawaki T, Kohriyama T, Matsumoto M. Therapeutic effects of intensive inpatient rehabilitation in advanced Parkinson's disease. Neurol Clin Neurosci. 2017;5:18–21. doi: 10.1111/ncn3.12088.
Kannarkat GT, Rafferty MR, Luo S, Liu H, Mills KA. Effect of exercise and rehabilitation therapy on risk of hospitalization in Parkinson's disease. Mov Disord Clin Pract. 2022;9:494–500. doi: 10.1002/mdc3.13456.
Downloads
Published
How to Cite
License
Copyright (c) 2025 Internal Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
